The compounds 2-(5-methylthiomethyl-2-furyl)-2-hydroxy-3-keto-4- dihydroxyethylbutyrolactone and 2-(5-methoxymethyl-2- furyl)-2-furyl(-2-hydroxy-3-keto-4-dihydroxyethylbutyrolactone and pharmaceutical compositions containing them are useful to regulate the immune response in mammals.
Method of treating inflammation in mammals utilizing ketobutyrolactones
申请人:American Biotechnology Company
公开号:US04883813A1
公开(公告)日:1989-11-28
Treatment of inflammation in mammals utilizing selected ketobutyrolactones and furylbutyrolactones. Treatment is applicable to both acute or chronic inflammation. Antiviral activity of methylfurylbutyrolactone is also disclosed.
[EN] USE OF MTMFBL AND RELATED COMPOUNDS AS IMMUNOMODULATORY AGENTS
申请人:AMERICAN BIOTECHNOLOGY COMPANY
公开号:WO1991002733A1
公开(公告)日:1991-03-07
(EN) 2-(5-methylthiomethyl-2-furyl)-2-hydroxy-3-keto-4-dihydroxyethylbutyrolactone, the corresponding 5-methoxymethyl compound, pharmaceutical compositions containing the compounds and method of use.(FR) 2-(5-méthylthiométhyl-2-furyl)-2-hydroxy-3-céto-4-dihydroxyéthylbutyrolactone, le composé de 5-méthoxyméthyle correspondant, compositions pharmaceutiques contenant les composés et mode d'emploi.